Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/the-feasibility-of-18f-fluorothymidine-pet-for-prediction-of-tumor-1Cu0rLpXkd
References (29)
-
Sang Lee, S. Oh, D. Chi, H. Kil, E. Kim, J. Ryu, D. Moon (2007)
Simple and highly efficient synthesis of 3′-deoxy-3′-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solventEuropean Journal of Nuclear Medicine and Molecular Imaging, 34
-
D. Francis, Dimitris Visvikis, Durval Costa, T. Arulampalam, C. Townsend, S. Luthra, Irving Taylor, P. Ell (2003)
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 30
-
M. Westerterp, H. Westreenen, J. Reitsma, O. Hoekstra, J. Stoker, P. Fockens, P. Jager, B. Eck-Smit, J. Plukker, J. Lanschot, G. Sloof (2005)
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.Radiology, 236 3
-
Wei Chen, S. Delaloye, D. Silverman, Cheri Geist, J. Czernin, J. Sayre, N. Satyamurthy, W. Pope, A. Lai, M. Phelps, T. Cloughesy (2007)
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 30
-
L. Kenny, R. Coombes, D. Vigushin, A. Al-Nahhas, S. Shousha, E. Aboagye, E. Aboagye (2007)
Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 34
-
F. Flanagan, F. Dehdashti, B. Siegel, D. Trask, S. Sundaresan, G. Patterson, J. Cooper (1997)
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.AJR. American journal of roentgenology, 168 2
-
Wei Chen, T. Cloughesy, N. Kamdar, N. Satyamurthy, M. Bergsneider, L. Liau, P. Mischel, J. Czernin, M. Phelps, D. Silverman (2005)
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 46 6
-
B. Klaeser, E. Nitzsche, J. Schuller, D. Köberle, L. Widmer, S. Balmer-Majno, T. Hany, Corinne Cescato-Wenger, P. Brauchli, M. Zünd, B. Pestalozzi, C. Caspar, S. Albrecht, R. Moos, T. Ruhstaller (2009)
Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02)Oncology Research and Treatment, 32
-
SB Edge (2010)
Compton CC The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol, 17
-
Y. Yamamoto, Y. Nishiyama, N. Kimura, S. Ishikawa, M. Okuda, S. Bandoh, N. Kanaji, M. Asakura, M. Ohkawa (2008)
Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 35
-
A. Buck, G. Halter, H. Schirrmeister, J. Kotzerke, I. Wurziger, G. Glatting, T. Mattfeldt, B. Neumaier, S. Reske, M. Hetzel (2003)
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 44 9
-
V. Gebski, B. Burmeister, B. Smithers, K. Foo, J. Zalcberg, J. Simes (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.The Lancet. Oncology, 8 3
-
H. Westreenen, D. Cobben, P. Jager, H. Dullemen, J. Wesseling, P. Elsinga, J. Plukker (2005)
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 46 3
-
F. Lordick, K. Ott, B. Krause (2010)
New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.Annals of oncology : official journal of the European Society for Medical Oncology, 21 Suppl 7
-
H. Wieder, H. Geinitz, R. Rosenberg, F. Lordick, K. Becker, A. Stahl, E. Rummeny, J. Siewert, M. Schwaiger, J. Stollfuss (2007)
PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 34
-
Uwe Haberkorn, L. Strauss, A. Dimitrakopoulou, R. Engenhart, F. Oberdorfer, Hermann Ostertag, J. Romahn, G. Kaick (1991)
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 32 8
-
Julius Leyton, J. Latigo, Meg Perumal, H. Dhaliwal, Qimin He, E. Aboagye (2005)
Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo.Cancer research, 65 10
-
K. Ott, W. Weber, F. Lordick, K. Becker, R. Busch, K. Herrmann, H. Wieder, U. Fink, M. Schwaiger, J. Siewert (2006)
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 29
-
R. Ullrich, T. Zander, B. Neumaier, Mirjam Koker, T. Shimamura, Y. Waerzeggers, Christa Borgman, S. Tawadros, Hongfeng Li, M. Sos, H. Backes, G. Shapiro, J. Wolf, A. Jacobs, Roman Thomas, A. Winkeler (2008)
Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET)PLoS ONE, 3
-
Betty Pio, Cecilia Park, R. Pietras, W. Hsueh, N. Satyamurthy, M. Pegram, J. Czernin, M. Phelps, D. Silverman (2005)
Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to TherapyMolecular Imaging and Biology, 8
-
Wolfgang Weber, K. Ott, K. Becker, H. Dittler, H. Helmberger, N. Avril, G. Meisetschläger, R. Busch, J. Siewert, M. Schwaiger, Ulrich Fink (2001)
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 12
-
P. Shreve, Y. Anzai, R. Wahl (1999)
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.Radiographics : a review publication of the Radiological Society of North America, Inc, 19 1
-
K. Chao (2006)
Functional imaging for early prediction of response to chemoradiotherapy: 3'-deoxy-3'-18F-fluorothymidine positron emission tomography--a clinical application model of esophageal cancer.Seminars in oncology, 33 6 Suppl 11
-
A. Shields, J. Grierson, B. Dohmen, H. Machulla, Joseph Stayanoff, Jawana Lawhorn-Crews, J. Obradovich, O. Muzik, T. Mangner (1998)
Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 4
-
R. Kubota, S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, T. Ido (1992)
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 33 11
-
J. Yue, Lusheng Chen, A. Cabrera, Xin-dong Sun, Shu-qiang Zhao, F. Zheng, A. Han, Jinsong Zheng, X. Teng, Li Ma, Yi-dong Ma, Dali Han, Xianguang Zhao, D. Mu, Jinming Yu, Yuhui Li (2010)
Measuring Tumor Cell Proliferation with 18F-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical StudyJournal of Nuclear Medicine, 51
-
S. Edge, C. Compton (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 17
-
K. Herrmann, H. Wieder, A. Buck, M. Schöffel, B. Krause, F. Fend, T. Schuster, C. Büschenfelde, H. Wester, J. Duyster, C. Peschel, M. Schwaiger, T. Dechow (2007)
Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's LymphomaClinical Cancer Research, 13
-
S. Malaisrie, W. Hofstetter, A. Correa, J. Ajani, R. Komaki, D. Rice, A. Vaporciyan, G. Walsh, J. Roth, Tsung-Teh Wu, S. Swisher (2006)
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinomaCancer, 107
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Korean Society of Nuclear Medicine
- Subject
- Medicine & Public Health; Imaging / Radiology; Oncology; Cardiology; Nuclear Medicine; Orthopedics
- ISSN
- 1869-3474
- eISSN
- 1869-3482
- DOI
- 10.1007/s13139-011-0118-4
- pmid
- 24900033
- Publisher site
- See Article on Publisher Site
Abstract
Nucl Med Mol Imaging (2012) 46:57–64 DOI 10.1007/s13139-011-0118-4 ORIGINAL ARTICLE The Feasibility of F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer Seol Hoon Park & Jin-Sook Ryu & Seung-Jun Oh & Seung-Il Park & Yong Hee Kim & Hoon-Yong Jung & Gin Hyug Lee & Ho Jun Song & Jong Hoon Kim & Ho-Young Song & Kyoung Ja Cho & Sung-Bae Kim Received: 16 September 2011 /Revised: 2 November 2011 /Accepted: 3 November 2011 /Published online: 3 January 2012 # Korean Society of Nuclear Medicine 2011 Abstract Methods This study was prospectively performed as a Purpose The aim of this study was to determine whether collateral study of “randomized phase II study of preoperative F-fluorothymidine (FLT) PET is feasible for the early concurrent chemoradiotherapy with or without induction prediction of tumor response to induction chemotherapy chemotherapy with S-1/oxaliplatin in patients with resectable followed by concurrent chemoradiotherapy in patients with esophageal cancer”. F-FLT positron emission tomography esophageal cancer. (PET) images were obtained before and after two cycles of induction chemotherapy, and the percent change of maxi- mum standardized uptake value (SUVmax) was calculated. : : S. H.
Journal
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Jan 3, 2012